About us Trusted for our single-cell, qPCR, and omics expertise

Single Cell Discoveries is a science-led CRO that brings together deep expertise across transcriptomics, qPCR, proteomics, and data analysis. From exploratory research to validated services, our scientists help researchers choose the right approach, generate high-quality data in our laboratories in the Netherlands and Sweden, and get meaningful answers to complex biological questions.

Meet the Team  Consortia

The leading CRO for multiomics and qPCR

Single Cell Discoveries brings together deep expertise in advanced discovery and precision validation to support pharmaceutical and biotechnology companies across drug development.
From single-cell and spatial biology to data analysis, proteomics, qPCR and dPCR, our teams in the Netherlands and Sweden help customers discover biological signals, understand what matters and translate those findings into robust assays for further development.

History

Two scientific legacies. One precision biology CRO.

Single Cell Discoveries grew out of the Van Oudenaarden lab at the Hubrecht Institute in Utrecht, where co-founder Mauro Muraro developed SORT-seq, a plate-based single-cell RNA sequencing method published in 2016. This work helped establish the Single Cell Core Facility at the Hubrecht Institute, led by Judith Vivié.

In 2018, Mauro Muraro and Judith Vivié founded Single Cell Discoveries to make single-cell sequencing technologies available as a service to researchers. Since then, SCD has expanded its capabilities across single-cell and spatial transcriptomics, bulk RNA sequencing, multi-omics, and data analysis. SCD became a certified service provider for numerous technology providers, including 10x Genomics, Parse Biosciences & BioSkryb Genomics.

In 2026, Single Cell Discoveries acquired TATAA Biocenter, an SCD company, expanding SCD's capabilities into qPCR, dPCR, proteomics, assay development, and regulated bioanalysis.
TATAA was founded in 2001 and has more than two decades of experience in molecular analysis, particularly qPCR and dPCR. Its Gothenburg laboratory adds GLP-accredited and GCLP-compliant capabilities for preclinical and clinical studies.

Today, SCD combines expertise across transcriptomics, PCR, proteomics, data analysis, and regulated bioanalysis.

Our expertise spans two sides of drug development that are often separated: advanced biological discovery and downstream validation. In Utrecht, our scientists specialize in single-cell and spatial biology, transcriptomics, technology development, and data analysis. In Gothenburg, our scientists bring decades of expertise in qPCR, dPCR, molecular assay development, proteomics, and regulated bioanalysis.

Together, we can help customers move from discovering biological signals to validating and measuring them as their programs progress.

Single cell sequencing Illumina NovaSeq scientist places samples in the new NovaSeq X machine
Scientist performing GLP-compliant bioanalysis in the TATAA Biocenter laboratory, supporting cell and gene therapy development with advanced bioanalytical services

Mission

To support scientists with their molecular and omics programs by providing deep expertise, tailored solutions, and high-quality data that enable confident and faster decision-making.

Vision

To help translate biology into medicine through the power of molecular & omics technologies.

CERTIFIED SERVICE PROVIDERS

Proudly certified to deliver trusted solutions across leading technologies.

QUALITY ASSURANCE & COMPLIANCE
Founders

Mauro Muraro

CO-FOUNDER AND CEO

Mauro Muraro, PhD, leads scientific and technical initiatives and is closely involved with client relationships, excelling in bespoke project design and complex data analysis. Before co-founding Single Cell Discoveries, Mauro developed the SORT-seq platform in the Van Oudenaarden Lab at the Hubrecht Institute, where he earned his PhD. Mauro is eager to continue innovating new methods in the single-cell field to accelerate biological discovery for clients and realize the potential of single-cell insights in clinical settings.

Judith Vivié

CO-FOUNDER AND COO

Judith Vivié runs laboratory and quality assurance operations. Before co-founding Single Cell Discoveries and after completing her masters, Judith led the single-cell sequencing core facility at the Hubrecht Institute, one of the first facilities in the world to make single-cell innovations accessible to academic and biopharmaceutical clients. There, she earned the nickname "mother of robots" for her unparalleled ability to integrate smart automation into single-cell workflows. Judith is dedicated to continuing to standardize and perfect single-cell workflows to bring the highest quality data to clients.

Your Scientists' Favorite Scientists

CO-FOUNDER AND CEO

Judith Vivié
CO-FOUNDER AND COO

Mathias Hallin
Director Sweden

Jack O'Sullivan
VICE PRESIDENT OF COMMERCIAL OPERATIONS

Dylan Mooijman
CHIEF TECHNOLOGY OFFICER (CTO)

Maria Enev
CHIEF FINANCIAL OFFICER (CFO)

HEAD OF DATA SCIENCE

Sofia Adolfsson
SCIENTIFIC OFFICER

Maria Janeh
Head of Quality Assurance

Advisory board

Prof. Alexander van Oudenaarden

ADVISORY BOARD MEMBER

Prof. Alexander van Oudenaarden is the director of the Hubrecht Institute for Developmental Biology and Stem Cell Research, a Professor of Quantitative Biology of Gene Regulation at the University Medical Center Utrecht and Utrecht University, and a Spinoza Price recipient. He is a leading researcher in stem cell biology and a pioneer of single-cell technologies. The Van Oudenaarden lab is innovating new methods in single cell multi-omics and maintains a collaborative relationship with Single Cell Discoveries.

Prof. John Groten

ADVISORY BOARD MEMBER

Prof. John Groten is the managing director of PamGene and visiting professor at Wageningen University & Research. He is an experienced business leader with over 30 years of management experience in life science research companies. He sees his role as "a change manager to enhance quality, creativity, and business insights into organizations."

Menzo Havenga, PhD

ADVISORY BOARD MEMBER

Menzo Havenga, PhD, is founder, president and CEO of Batavia Biosciences and Batavia Biopharma. He previously worked as the Managing Director of Biosciences Business at TNO and Vice President of Research and Development at Crucell, as well as holding a PhD in molecular virology from Leiden University.

COLLABORATIONS AND CONSORTIA

Partnerships play a dual role in our operations. In alignment with our vision, we work on projects that help adapt single-cell applications to diagnostic and therapeutic purposes. Meanwhile, we access resources and experience that fuel our own evolution.

Careers

Enjoy working
alongside top talent to achieve a shared goal?

Passionate about advancing biological understanding through the power of multiomics and bioanalyses? Apply today to join the team.